Heterozygous ABCC8 mutations are a cause of MODY.

No Thumbnail Available
Authors
Bowman, Pamela
Flanagan, Sarah
Edghill, E. L.
Damhuis, A.
Shepherd, Maggie
Paisey, R.
Hattersley, Andrew T.
Ellard, Sian
Journal
Diabetologia
Type
Research Support, Non-U.S. Gov't
Publisher
Springer
Rights
Archived with thanks to Diabetologia
The ABCC8 gene encodes the sulfonylurea receptor 1 (SUR1) subunit of the pancreatic beta cell ATP-sensitive potassium (K(ATP)) channel. Inactivating mutations cause congenital hyperinsulinism (CHI) and activating mutations cause transient neonatal diabetes (TNDM) or permanent neonatal diabetes (PNDM) that can usually be treated with sulfonylureas. Sulfonylurea sensitivity is also a feature of HNF1A and HNF4A MODY, but patients referred for genetic testing with clinical features of these types of diabetes do not always have mutations in the HNF1A/4A genes. Our aim was to establish whether mutations in the ABCC8 gene cause MODY that is responsive to sulfonylurea therapy.
Citation
Heterozygous ABCC8 mutations are a cause of MODY. 2012, 55 (1):123-7 Diabetologia
Note
This article is freely available via Open Access. Click on the ‘Additional Link’ above to access the full-text from the publisher’s site.